Accelmed Partners Ii L.P. is > 10% Shareholder of NeuroPace Inc. Currently has a direct ownership of 4.43 Million shares of NPCE, which is worth approximately $30.8 Million. The most recent transaction as insider was on Nov 22, 2022, when has been sold 62,398 shares (Common Stock) at a price of $1.5 per share, resulting in proceeds of $93,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.43M
0% 3M change
0% 12M change
Total Value Held $30.8 Million

Accelmed Partners II L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2022
BUY
Open market or private purchase
$93,597 $1.5 p/Share
62,398 Added 1.39%
4,432,948 Common Stock
Nov 21 2022
BUY
Open market or private purchase
$491,839 $1.5 p/Share
327,893 Added 6.98%
4,370,550 Common Stock
Apr 26 2021
BUY
Conversion of derivative security
-
3,454,422 Added 46.08%
4,042,657 Common Stock
Apr 21 2021
BUY
Open market or private purchase
$9,999,995 $17.0 p/Share
588,235 Added 50.0%
588,235 Common Stock
API

Accelmed Partners Ii L.P.

> 10% Shareholder
Aventure, FL

Track Institutional and Insider Activities on NPCE

Follow NeuroPace Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NPCE shares.

Notify only if

Insider Trading

Get notified when an Neuro Pace Inc insider buys or sells NPCE shares.

Notify only if

News

Receive news related to NeuroPace Inc

Track Activities on NPCE